Lung cancer staging is the assessment of the degree to which lung cancer has spread from its original source. Correct staging of lung cancer is extremely important for the treatment planning process. Lung cancer spreads in a fairly predictable pattern. A tumor may initially be discovered in various portions of the lung. The cancer then generally spreads to lymph nodes close to the original tumor, followed by lymph nodes further away in a space called the mediastinum. Initially, in the mediastinum, cancer will infect lymph nodes on the same side as the tumor. However, as the cancer progresses, the cancer may spread to lymph nodes on the opposite side of the tumor. In very advanced stages, lung cancer may spread to distant organs. By determining how far the cancer has spread, a cancer stage can be determined and a proper course of treatment may be planned.
The TNM (Tumor Node Metastasis) classification system is an internationally accepted staging system, which classifies the degree of severity of the cancer. An internationally accepted classification system facilitates the exchange of information between treatment facilities and contributes to the appropriate treatment of cancer. The ‘T’ (tumor) indicates the size or direct extent of the primary tumor. The ‘N’ (lymph nodes) indicates the involvement of regional lymph nodes. The ‘M’ indicates whether distant metastasis (e.g., the spread of cancer from one body part to another) exists. Thus, after a tumor is initially identified and classified, surrounding lymph nodes may be biopsied to determine the extent that the cancer has spread for accurate cancer staging.
A method for identifying a tumor in a patient image, classifying the tumor based on a predetermined classification system and determining a recommendation regarding a lymph node biopsy based on the tumor identified in the patient image, the classification of the tumor and a predetermined rule.
A system having a display displaying a patient image, a processor classifying a tumor displayed in the patient image based on a predetermined classification system and determining a recommendation regarding a lymph node biopsy based on the tumor in the patient image, the classification of the tumor and a predetermined rule.
A computer-readable storage medium including a set of instructions executable by a processor. The set of instructions operable to identify a tumor in a patient image, classify the tumor based on a predetermined classification system and determine a recommendation regarding a lymph node biopsy based on the tumor identified in the patient image, the classification of the tumor and a predetermined rule.
The exemplary embodiments may be further understood with reference to the following description and the appended drawings wherein like elements are referred to with the same reference numerals. The exemplary embodiments provide a visualization system and method for generating patient-specific recommendations regarding lymph node biopsies, based on the TNM classification system. It will be understood by those of skill in the art that although the exemplary embodiments specifically describe lung cancer staging, the following system and method may be used to provide patient-specific recommendations for cancer staging of other types of cancers.
As shown in
As shown in
After the tumor has been identified and classified, the system 100 prompts the user to indicate a next step to be taken. For example, the user may indicate, via the user interface, a request for recommendations regarding lymph node biopsies and/or a request to save, print or display the identified tumor information. When the user indicates the request for lymph node biopsy recommendation, the processor 102 maps the patient medical image to a general atlas, in a step 240. The general atlas includes a model lung and/or bronchial tree with numbered nodal stations, according to the TNM classification system. For example, the current accepted TNM classification system includes fourteen nodal stations that are numbered based upon a location in the lung/bronchial tree. Nodes 1-9 are located in the mediastinum while nodes 10-14 are hilar and intrapulmonary lymph nodes. The patient medical image is mapped to the general atlas such that a corresponding one of the fourteen numbered nodal stations of the general atlas is mapped to lymph node regions in the patient medical image and the tumor identified in the patient medical image is correlated with a corresponding tumor (e.g., by size and position) in the general atlas. It will be understood by those of skill in the art, however, that where a position of the tumor is not a factor in determining recommendations of lymph nodes for biopsy, mapping the patient medical to the general atlas may not be necessary until a later time.
In a step 250, the processor 102 analyzes the general atlas to determine recommendations for an optimal number, location and/or order of lymph nodes to be biopsied based upon predetermined rules. The rules are based upon factors such as, the classification of the primary tumor, a position or distance of the nodal stations relative to the tumor, a position of the lymph node within the body, a position of the nodal stations relative to a drainage area, a staging scheme of the TNM classification system and known information based upon previously staged tumors. For example, according to the currently accepted TNM classification system, nodes 1-9 represent N2 lymph nodes, meaning that if a biopsy of any of these lymph nodes indicates involvement of cancer, the N will be classified as a N2. Nodes 10-14, on the other hand, represent N1 nodes such that if a biopsy reveals cancer involvement in any of the nodes labeled 10-14, the N will be classified as N1. Some of the nodes may also be given an R (right) and L (left) classification depending on the location of the identified tumor. An N3 classification would indicate that the cancer has traveled to a node on a side of the lung opposite of the location of the identified tumor. It will be understood by those of skill in the art that the rules may be defined and/or changed by the user and stored in the memory 108.
In a step 260, the recommendation of lymph nodes to be biopsied is displayed on the display 106, as shown in
In a step 280, the general atlas including the recommended lymph nodes to be biopsied are mapped to the lung segmentation and/or bronchial tree extraction to indicate a patient-specific location of each of the recommended lymph nodes. In a step 290, the lung segmentation and/or the bronchial tree extraction showing the corresponding lymph nodes relative to the lung segmentation and the bronchial tree extraction is displayed on the display 106, as shown in
It will be apparent to those skilled in the art that various modifications may be made in the present disclosure, without departing from the spirit or the scope of the disclosure. Thus, it is intended that the present disclosure cover modifications and variations of this disclosure provided they come within the scope of the appended claims and their equivalents.
It is also noted that the claims may include reference signs/numerals in accordance with PCT Rule 6.2(b). However, the present claims should not be considered to be limited to the exemplary embodiments corresponding to the reference signs/numerals.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2010/052670 | 6/15/2010 | WO | 00 | 2/23/2012 |
Number | Date | Country | |
---|---|---|---|
61222675 | Jul 2009 | US |